BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile


Ernst & Young LLP 

Global Biotechnology Center
200 Clarendon Street
Boston  Massachusetts  02116  U.S.A.
Phone: 617-859-6400 Fax: 617-266-5843


Ernst & Young pioneered professional services in support of biotechnology and is recognized as the leader in serving the industry. Since the industry's inception, Ernst & Young has consistently met the changing business needs of biotech companies, helping them address a range of critical business issues including:

- Product development and commercialization
- Strategic asset management
- Regulatory strategy and compliance
- Financial planning
- Information systems and technology
- Business performance improvement
- International business development
- Business planning
- New venture development
- Corporate development
- Strategic partnering
- International tax strategy
- Transactions
- Corporate finance
- Worldwide accounting, auditing, and tax

Ernst and Young biotechnology service teams are part of an extensive global network of professionals with industry-specific backgrounds. Our service philosophy is based on the effective integration of the people, processes, and technology for enterprise-wide improvement.

Ernst & Young is committed to supporting companies within each phase of the life sciences industry life cycle. Whether yours is a mature company or a visionary start-up, we can help. Our long-standing commitment to life sciences companies, coupled with our technical services capabilities, makes Ernst & Young the firm of choice for the biotechnology industry.

 Key Statistics

Ownership: Private

Web Site: Ernst & Young LLP


 Company News
PDL BioPharma, Inc. (PDLI) Issues Statement On Resignation Of Ernst & Young LLP As Corporate Auditors 9/18/2014 8:15:57 AM
Advanced Cell Technology Announces Paul K. Wotton Ph.D. Recognized As Ernst & Young LLP 2014 Entrepreneur Of The Year™ For New Jersey Region 7/1/2014 10:33:53 AM
Atherotech Diagnostics Lab President And CEO Wins Ernst & Young LLP Entrepreneur Of The Year Award 6/30/2014 10:02:47 AM
Intrexon Corporation Appoints Former Ernst & Young LLP CEO James S. Turley To Board Of Directors 4/17/2014 6:23:12 AM
NPS Pharmaceuticals, Inc. (NPSP)’ President And CEO Dr. Francois Nader Receives Ernst & Young LLP National Entrepreneur Of The Year® 2013 Award In The Life Sciences Category 11/18/2013 10:09:30 AM
Ernst & Young LLP Announces Labcyte Inc. CEO and President Mark Fischer-Colbrie and Co-Founder Rich Ellson as the Entrepreneur Of The Year® 2013 Award Winner in Northern California 7/24/2013 9:53:13 AM
Greenphire and Ernst & Young LLP Announce Strategic Partnership 7/9/2013 10:47:43 AM
Ariad Pharmaceuticals, Inc. (ARIA) Chief Executive Officer, Harvey J. Berger, M.D., Recognized as 2013 Ernst & Young LLP Entrepreneur of the Year® in New England 6/28/2013 9:39:00 AM
Angel Medical Systems CEO Dr. David R. Fischell Wins Ernst & Young LLP Entrepreneur of the Year® Award 6/18/2013 9:08:25 AM
Santarus Inc. (SNTS) President & CEO Gerald Proehl Honored as San Diego Ernst & Young LLP Entrepreneur of the Year 2013 in Life Sciences 6/17/2013 9:20:42 AM